🆕 Greater transparency for oncology clinical trials reporting Chief Editors of The Lancet’s specialty journals discuss enhanced scrutiny in the reporting of oncology clinical trials Read here: thelancet.com/journals/lan...

Hope you are enjoying the presentations at #ISMRM2026. Feel free to reach out if you would like to discuss potential submissions to the journal with the editorial team!

🎉Proud to share our first online article by @nathaliealbert.bsky.social & colleagues that was presented at #NMN2026 @nmnsymposium.bsky.social www.thelancet.com/action/showF...

📌In case you missed it📌 You can watch our webinar on Publishing Excellence with The Lancet Medical Imaging & Theranostics on demand now ➡️ hubs.li/Q042sbkM0 Many thanks to all who attended live and provided us with some great discussion points

Our editor in chief, Ali Landman, will attend @nmnsymposium.bsky.social in Vienna, May 7-8. Please reach out if you would like to discuss about our new journal, your research and potential collaborations! #NMN2026

📅 This time next week, please join us for our webinar on Publishing Excellence with The Lancet Medical Imaging & Theranostics Register here to attend live or to receive a link to the recording ➡️ hubs.li/Q042sbn40

📢 Join our webinar on publishing excellence on April 30, 2026, 15.00 BST/10.00 EDT Register to attend live or receive the link to the on-demand version when available ➡️https://hubs.li/Q042sbn40

Retroperitoneal fibrosis is a rare immune-mediated disease which can be classified as idiopathic or secondary. A new Seminar provides an overview of retroperitoneal fibrosis focusing on pathophysiology, differential diagnosis, and management: spkl.io/63323AFbdz

📢 Have you registered yet? Register now: hubs.li/Q042sbn40 Join our editorial team as we share insights on their journal's aims and scope, what we look for in a research paper, and best practices for preparing your manuscript. #MedSky #RadSky

🔎 Want to learn more about the journal's aims and scope and what we are looking for in a research paper? 🎬 Join us on April 30th for a webinar on publishing excellence with The Lancet Medical Imaging & Theranostics For more information and to register see ➡️ hubs.li/Q042sbn40

💡 Stay connected to your field. Access our late-breaking content, Series and Commissions, and learn about our involvement at global conferences. Register for Lancet Conference Alerts today: hubs.li/Q045K7ZC0 #Radiology #MedicalImaging #Radsky

🆕 Introducing The Lancet Regional Health – Eastern Mediterranean, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in the Eastern Mediterranean. Discover the new addition to The Lancet Group at: spkl.io/63328AFIyw#goldopenaccess#medsky

This month's podcast: James Nagarajah on [177Lu]-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study 🎧 Listen & subscribe! Spotify: open.spotify.com/show/3JOj0Cl... Apple: podcasts.apple.com/us/podcast/t...

Have you signed up for alerts from The Lancet Medical Imaging & Theranostics yet?   Register for Table of Contents & Online First Alerts, sent monthly from when our first issue is available, or weekly for Online First content. Sign up to Journal Alerts here hubs.li/Q045JY-R0 #goldopenaccess

🎧NEW podcast Our editor-in-chief, Ali Landman talked with Cheryl Lai, deputy editor of @thelancetoncol.bsky.social about our journal, its scope, the team. She also shared her takeaways from the European Congress of Radiology #ECR. #RadSky

Our new issue is out now 🎉 We feature research on #bladdercancer, routine testing for detection of #syphilis, and point-of-care testing strategies for #antibioticprescribing for respiratory tract infections, and more! Explore and download the issue on our journal homepage: hubs.li/Q03yqV6c0.

Thinking where to submit your next manuscript? We’re inviting quality, original research in clinical and technological advances in #radiology, nuclear medicine and theranostics. APCs will be waived on accepted Articles submitted by Sep 2, 2026. Learn more: hubs.li/Q045K3jl0 #goldopenaccess

This Monday is the 26th Annual @roysocmed.bsky.social #PET day. Our editor in chief, Ali Landman, and our senior editor, Ankita Das will be there. Please reach out if you want to discuss about the journal, your research and potential collaborations! www.rsm.ac.uk/events/radio...

Our March issue is now online: www.thelancet.com/journals/lan... Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #malaria #HIV #Streptococcus #PCV #RiftValleyFever #pertussis #tuberculosis #TB #AMR #IDSky #ClinMicro #TBSky #OA

📅 Save the date 📅 Join our editorial team on Thursday April 30th for a webinar on publishing excellence with The Lancet Medical Imaging and Theranostics, a new open access journal within the Lancet group. 👉Register to attend hubs.li/Q042sbn40 🗓️ Thurs, April 30, 2026 🕒15:00 BST / 10:00 EDT

Our editor in chief, Ali Landman, is still attending #ECR2026. Feel free to reach out if you would like to discuss the journal or your research! www.linkedin.com/feed/update/...

🆕Our March issue is live! 📊Articles: #prostatecancer, #breastcancer, #melanoma, and #brachytherapy 📰Reviews: #ESTRO concensus on RT for more efficacious novel anticancer drugs + a expert consensus on oligometastatic pancreatic cancer www.thelancet.com/issue/S1470-...

Our Editor-in-Chief, Ali Landman, will be at #ECR2026 in Vienna, March 4-8, and she invites you to reach out with any questions about the journal or if you'd like to discuss your research. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q042qY8P0

📣 Speakers announced! 14 academic and lived experience experts will lead an exceptional programme at The #LancetSummit: shaping the future of #diabetes prevention. Submit your abstract by Jun 12 to join them: hubs.li/Q03MV4_x0

A clinical trial from @thelancetoncol.bsky.social explores whether advanced PET imaging improves outcomes over standard MRI for guiding re-irradiation in recurrent glioblastoma. It aligns with our journal's focus on how imaging influence treatment & patient lives 🔓https://bit.ly/thelancet-lanonc-642

🎤 A word from our editor in chief, Ali Landman: “The specialty is seeing rapid innovation thanks to new biological, chemical, and physical discoveries, as well as the advent of AI, and I feel excited and privileged to work with researchers and clinicians across disciplines”

🚀 Just launched – our new #goldopenaccess journal on medical imaging and theranostics! Learn more about the journal’s mission and explore related content from The Lancet Group today: hubs.li/Q041CgFF0 #medsky